Delivery Order SPE2DB22D2211-SPE2DB25FSDRP
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Fexofenadine HCL 180 mg tablets (100-count packages) under a firm fixed-price contract valued at $1,149.62. The award was made on June 4, 2025, with an ultimate completion date of June 5, 2025, and represents a non-competitive, non-set-aside delivery order. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this contract at its corporate office location in the same...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Fexofenadine HCl 180 mg tablets (500 count) with a ceiling value of $1,288.32. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 14, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $7,265.19 to AmerisourceBergen Drug Corp for Fexofenadine HCL 180 mg tablets (500 count) with an ultimate completion date of August 13, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a child contract under a larger vehicle. The delivery location is the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Fexofenadine HCL 180 mg tablets in a quantity of 500 units, valued at $2,287.74. This competitively awarded, firm fixed-price delivery order is non-set-aside and will be performed at the contractor's Conshohocken, Pennsylvania location, with an ultimate completion date of September 9, 2025. The award represents a child delivery order under a larger contract vehicle,...
- This is a $1,931.76 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for the supply of Fexofenadine HCL 180 mg tablets, a prescription medication, with a period of performance through July 2, 2025. The contract is not set aside and represents an open competition award. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Fexofenadine HCL 180 mg tablets (500 count) with a contract ceiling value of $1,811.12. This firm fixed-price delivery order, with an ultimate completion date of September 12, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The contract was competitively awarded without a set-aside designation, and performance...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,695.76 firm fixed-price delivery order is for the supply of 4,568,250,656 units of Fexofenadine HCL 180 mg tablets. The contract has an ultimate completion date of May 15, 2025 and is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The $1,778.02 firm fixed-price delivery order is for the supply of 500 tablets of the pharmaceutical product Fexofenadine HCl 180 mg. The contract has an ultimate completion date of July 1, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of Fexofenadine HCL 180 mg tablets. The contract is a Delivery Order with a Firm Fixed Price type, valued at $1,422.24, and has a period of performance through February 21, 2024. The contract was not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp holds a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,010.19, is a delivery order for the supply of Fexofenadine HCL 180 mg tablets. It is a firm fixed-price contract with a completion date of February 26, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSDRPDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Fexofenadine HCL 180 mg tablets (500-count) valued at $1,022.88 under a firm fixed-price contract. The award was made on August 26, 2025, with an ultimate completion date of August 27, 2025, and represents a non-competitive, non-set-aside procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The firm's extensive federal contract portfolio demonstrates its capability to fulfill diverse medical procurement requirements across multiple therapeutic domains through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 8/26/25 |